Table 1. Clinical and pathological characteristics of the study cohort.
| n | 1108 | |
|---|---|---|
| Age (yrs) | Median | 61.5 |
| Range | 40.2-79 | |
| PSA (ng/ml) | Median | 6.99 |
| Range | 0.3-20 | |
| Pathological Stage | pT2 | 770 (69.6%) |
| pT3 | 335 (30.4%) | |
| Tumour Grade | Low (GS 6) | 153 (13.8%) |
| Intermediate (GS 7) | 848 (76.5%) | |
| GS 3+4 | 583 (68.8%) | |
| GS 4+3 | 265 (31.3%) | |
| High (GS 8-10) | 107 (9.7%) | |
| Extraprostatic Extension | Absent | 782 (70.6%) |
| Present | 326 (29.4%) | |
| Seminal Vesicle Invasion | Absent | 1042 (94.1%) |
| Present | 66 (6%) | |
| Recurrence | No | 812 (76.8%) |
| (n=1057) | Yes | 245 (23.2%) |
| Total Tumour Volume (cc) | Median | 2.6 |
| IQR | 1.3-4.8 | |
| Prostate Volume (cc) | Median | 32.2 |
| IQR | 24.2-43.5 |